Clinical Trial Detail

NCT ID NCT02042443
Title Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

gallbladder carcinoma

bile duct carcinoma

Therapies

Fluorouracil + Leucovorin

Capecitabine

Trametinib

Age Groups: adult

No variant requirements are available.